RESEARCH TRIANGLE PARK — IQVIA has secured a deal with LMC Manna Research to launch what it says is the largest clinical research site in Canada.
That adds to its network of more than 980 Prime and Partner clinical sites globally.
IQVIA said it will collaborate with LMC Manna on research programs to “optimize processes, reduce the time to start clinical research, align procedures and support a significant increase in complex clinical and real-world evidence studies in Canada.”
“Our partnership with LMC Manna Research leverages a strong infrastructure and transformational technologies to bring research to communities across Canada,” said Richard Staub, president, Research and Development Solutions, IQVIA, in a statetement.
LMC Manna Research is the one of the largest wholly owned integrated research network in Canada, conducting phases I-IV studies at 22 trial sites across three provinces. IQVIA will provide staff dedicated to LMC Manna Research, including a prime site manager who will oversee partnership relations and follow up on the delivery of IQVIA research projects.
“We are excited to partner with IQVIA to co-develop strategies to improve clinical research in Canada and globally,” said Karri Venn, president, Research at LMC Manna Research, in a statement. “Our common commitment to bring meaningful research to patients while improving the entire continuum is magnified and made more tangible through this partnership. We look forward to collaborating across multiple domains to bring improvement to clinical research to both Canadians and the industry.”
